Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutation
Immune Dysregulation
DOI:
10.1016/j.jaci.2022.09.013
Publication Date:
2022-09-21T13:12:32Z
AUTHORS (25)
ABSTRACT
Forkhead box protein 3 (FOXP3) is the master transcription factor in CD4+CD25hiCD127lo regulatory T (Treg) cells. Mutations FOXP3 result IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome. Clinical presentation of syndrome broader than initially described, challenging understanding disease, its evolution, and treatment choice.We sought to study type extent immunologic abnormalities that remain ill-defined IPEX, across genetic clinical heterogeneity.We performed Treg-cell-specific epigenetic quantification characterization severe "typical" (n = 6) "atypical" or asymptomatic 9) patients with IPEX.Increased number cells Treg-cell-Specific Demethylated Region demethylation a consistent feature (1) highest values those typical (2) increased subjects pathogenic but still no symptoms, (3) gradual increase over course disease progression. Large-scale profiling using Luminex identified plasma inflammatory signature macrophage activation TH2 polarization, cytokines previously not associated pathology, including CCL22, CCL17, CCL15, IL-13, markers TNF-α, IL-1A, IL-8, sFasL, CXCL9. Similarly, both Treg-cell Teff compartments, studied by Mass Cytometry Time-Of-Flight, were skewed toward compartment, especially IPEX.Elevated TSDR-demethylated cells, combined elevation plasmatic cellular polarized 2 immune response, extends our diagnosis heterogeneity.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (61)
CITATIONS (22)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....